BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 2880864)

  • 1. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation.
    Reame NE; Sauder SE; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1985 Nov; 61(5):851-8. PubMed ID: 3900122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.
    Perkins RB; Hall JE; Martin KA
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1905-11. PubMed ID: 10372685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Foster CM; Brown MB; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1147-51. PubMed ID: 7962287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The source of pulsatile secretion of progesterone during the human follicular phase.
    Judd S; Terry A; Petrucco M; White G
    J Clin Endocrinol Metab; 1992 Feb; 74(2):299-305. PubMed ID: 1730808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP; Foster CM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4010-4. PubMed ID: 9398704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.
    Van Vugt DA; Lam NY; Ferin M
    Endocrinology; 1984 Sep; 115(3):1095-101. PubMed ID: 6745188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone infusion reduces nocturnal luteinizing hormone pulse frequency in pubertal boys.
    Foster CM; Hassing JM; Mendes TM; Hale PM; Padmanabhan V; Hopwood NJ; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1213-20. PubMed ID: 2685008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.
    Veldhuis JD; Evans WS; Demers LM; Thorner MO; Wakat D; Rogol AD
    J Clin Endocrinol Metab; 1985 Sep; 61(3):557-63. PubMed ID: 3926810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercortisolism in patients with functional hypothalamic-amenorrhea.
    Suh BY; Liu JH; Berga SL; Quigley ME; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1988 Apr; 66(4):733-9. PubMed ID: 3346352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone does not reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
    Kletter GB; Foster CM; Brown MB; Padmanabhan V; Beitins IZ; Marshall JC; Kelch RP
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1241-7. PubMed ID: 1955505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women.
    Loucks AB; Mortola JF; Girton L; Yen SS
    J Clin Endocrinol Metab; 1989 Feb; 68(2):402-11. PubMed ID: 2537332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.
    Santen RJ; Bardin CW
    J Clin Invest; 1973 Oct; 52(10):2617-28. PubMed ID: 4729055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.